DRDO’s ‘2-deoxy-D-glucose’ (2-DG) gets approval as adjunct therapy for Covid-19
The drug, ‘2Deoxy-D-glucose’ (2-DG), developed by the Defence Research and Development Organization (DRDO) has been approved by the Drug Controller General of India, for emergency use on Covid-19 patients.